Genomcore leads the debate on AI and Regulation at the AI in MedTech 2025 Summit in Portugal

The summit brought together European industry leaders to discuss AI implementation in healthcare. Genomcore's QARA Lead, Maria Diez Zaera, represented the company at this significant event focused on balancing "technological agility and regulatory rigor."

The event, which brought together European industry leaders, served to reaffirm Genomcore's commitment to an AI deployment that is, above all, safe, ethical and efficient. From the high-level sessions and debates, three strategic pillars emerged that define our roadmap:

• Compliance as an innovation driver: Far from being an obstacle, regulation is our guide. At Genomcore, we integrate AI within the quality system (QARA), ensuring that every technological advance strictly complies with European standards.

• Optimization with expert judgment: We understand technology as an amplifier of human talent. Our vision focuses on automating routine tasks so that healthcare professionals can devote their time to critical decision-making with clinical value.

• Multidisciplinary teams and collaboration: The future of MedTech belongs to those who can bridge data science with regulatory knowledge. This hybrid DNA is what enables Genomcore to develop solutions that inspire confidence in the medical community.

We thank the organizers, especially Sean Smith, Miguel Amador and the Complear team, for creating such a valuable space for industry exchange. At Genomcore, we continue working to ensure that technological infrastructure is the most reliable support for the medicine of the future.